Biostar Pharmaceuticals Inc

PINK:BSPM USA Drug Manufacturers - Specialty & Generic
Market Cap
$263.72
Market Cap Rank
#49618 Global
#15172 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$5.77
About

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common … Read more

Biostar Pharmaceuticals Inc (BSPM) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2017: 0.000x

Based on the latest financial reports, Biostar Pharmaceuticals Inc (BSPM) has a cash flow conversion efficiency ratio of 0.000x as of September 2017.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.41K) by net assets ($36.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Biostar Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2007–2016)

This chart illustrates how Biostar Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Biostar Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biostar Pharmaceuticals Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Biostar Pharmaceuticals Inc (2007–2016)

The table below shows the annual cash flow conversion efficiency of Biostar Pharmaceuticals Inc from 2007 to 2016.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2016-12-31 $36.88 Million $4.91 Million 0.133x +0.33%
2015-12-31 $44.27 Million $5.88 Million 0.133x +190.10%
2014-12-31 $72.34 Million $3.31 Million 0.046x -67.75%
2013-12-31 $62.77 Million $8.91 Million 0.142x +328.80%
2012-12-31 $57.77 Million $-3.58 Million -0.062x -154.02%
2011-12-31 $76.40 Million $8.77 Million 0.115x -45.90%
2010-12-31 $60.50 Million $12.84 Million 0.212x +53.09%
2009-12-31 $40.92 Million $5.67 Million 0.139x +514.00%
2008-12-31 $23.27 Million $-779.43K -0.033x -141.63%
2007-12-31 $16.29 Million $1.31 Million 0.080x --